{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:46:28Z","timestamp":1780447588693,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["11CVD04"],"award-info":[{"award-number":["11CVD04"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-126012"],"award-info":[{"award-number":["HL-126012"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-120732"],"award-info":[{"award-number":["HL-120732"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-128215"],"award-info":[{"award-number":["HL-128215"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["K08 HL-127305"],"award-info":[{"award-number":["K08 HL-127305"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["R03 HL-141620"],"award-info":[{"award-number":["R03 HL-141620"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP110486P3"],"award-info":[{"award-number":["RP110486P3"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["14SFRN20670003"],"award-info":[{"award-number":["14SFRN20670003"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["14SFRN20510023"],"award-info":[{"award-number":["14SFRN20510023"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.yjmcc.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T11:50:08Z","timestamp":1551268208000},"page":"188-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["HDAC inhibition as a therapeutic strategy in myocardial ischemia\/reperfusion injury"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2967-3490","authenticated-orcid":false,"given":"Min","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yida","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yjmcc.2019.02.013_bb0005","first-page":"e18","article-title":"Heart disease and stroke statistics\u20142011 update: a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2019.02.013_bb0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ahj.2007.06.020","article-title":"Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy","volume":"154","author":"Alegria","year":"2007","journal-title":"Am. Heart J."},{"issue":"8","key":"10.1016\/j.yjmcc.2019.02.013_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002049","article-title":"Infarct size, shock, and heart failure: does reperfusion strategy matter in early presenting patients with ST-segment elevation myocardial infarction?","volume":"4","author":"Shavadia","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/j.yjmcc.2019.02.013_bb0020","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2019.02.013_bb0025","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.111.032698","article-title":"New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop","volume":"124","author":"Schwartz Longacre","year":"2011","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.yjmcc.2019.02.013_bb0030","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","article-title":"Cyclosporine before PCI in patients with acute myocardial infarction","volume":"373","author":"Cung","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2019.02.013_bb0035","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.107.729780","article-title":"Long-term benefit of postconditioning","volume":"117","author":"Thibault","year":"2008","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.yjmcc.2019.02.013_bb0040","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/eurheartj\/eht090","article-title":"Myocardial reperfusion injury: looking beyond primary PCI","volume":"34","author":"Frohlich","year":"2013","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.yjmcc.2019.02.013_bb0045","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","article-title":"Critical issues for the translation of cardioprotection","volume":"120","author":"Heusch","year":"2017","journal-title":"Circ. Res."},{"issue":"2011","key":"10.1016\/j.yjmcc.2019.02.013_bb0050","article-title":"The tale of protein lysine acetylation in the cytoplasm","author":"Sadoul","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"4","key":"10.1016\/j.yjmcc.2019.02.013_bb0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molcel.2008.07.002","article-title":"Lysine acetylation: codified crosstalk with other posttranslational modifications","volume":"31","author":"Yang","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yjmcc.2019.02.013_bb0060","series-title":"Epigenetics in Cardiac Disease","author":"Backs","year":"2016"},{"key":"10.1016\/j.yjmcc.2019.02.013_bb0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-biophys-042910-155329","article-title":"Nucleosome structure(s) and stability: variations on a theme","volume":"40","author":"Andrews","year":"2011","journal-title":"Annu. Rev. Biophys."},{"issue":"4","key":"10.1016\/j.yjmcc.2019.02.013_bb0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrm2145","article-title":"Histone acetyltransferase complexes: one size doesn't fit all","volume":"8","author":"Lee","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.yjmcc.2019.02.013_bb0075","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacbts.2018.05.003","article-title":"Epigenetics in cardiac fibrosis: emphasis on inflammation and fibroblast activation","volume":"3","author":"Felisbino","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"issue":"1","key":"10.1016\/j.yjmcc.2019.02.013_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmb.2004.02.006","article-title":"Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis","volume":"338","author":"Gregoretti","year":"2004","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.yjmcc.2019.02.013_bb0085","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/bies.201600070","article-title":"Histone deacetylase inhibitors for cancer therapy: an evolutionarily ancient resistance response may explain their limited success","volume":"38","author":"Halsall","year":"2016","journal-title":"Bioessays"},{"issue":"7","key":"10.1016\/j.yjmcc.2019.02.013_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.yjmcc.2019.02.013_bb0095","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1096\/fj.08-108548","article-title":"Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice","volume":"22","author":"Granger","year":"2008","journal-title":"FASEB J."},{"issue":"2014","key":"10.1016\/j.yjmcc.2019.02.013_bb0100","article-title":"Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseases","author":"Wang","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2017","key":"10.1016\/j.yjmcc.2019.02.013_bb0105","article-title":"Suppression of excessive histone deacetylases activity in diabetic hearts attenuates myocardial ischemia\/reperfusion injury via mitochondria apoptosis pathway","author":"Wu","year":"2017","journal-title":"J. Diabetes Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2019.02.013_bb0110","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/jcp.24871","article-title":"HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia\/reoxygenation injury","volume":"230","author":"Du","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"44","key":"10.1016\/j.yjmcc.2019.02.013_bb0115","doi-asserted-by":"crossref","first-page":"17335","DOI":"10.1073\/pnas.0706487104","article-title":"Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases","volume":"104","author":"Lahm","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.yjmcc.2019.02.013_bb0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s10020-018-0037-2","article-title":"Myocyte-specific overexpressing HDAC4 promotes myocardial ischemia\/reperfusion injury","volume":"24","author":"Zhang","year":"2018","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2019.02.013_bb0125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cardiores.2007.08.010","article-title":"Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury","volume":"76","author":"Zhao","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.yjmcc.2019.02.013_bb0130","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.113.002416","article-title":"Histone deacetylase inhibition blunts ischemia\/reperfusion injury by inducing cardiomyocyte autophagy","volume":"129","author":"Xie","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2019.02.013_bb0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yjmcc.2019.02.013_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2018.04.011","article-title":"HDAC inhibition helps post-MI healing by modulating macrophage polarization","volume":"119","author":"Kimbrough","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"31","key":"10.1016\/j.yjmcc.2019.02.013_bb0145","doi-asserted-by":"crossref","first-page":"28930","DOI":"10.1074\/jbc.M303113200","article-title":"Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors","volume":"278","author":"Antos","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.yjmcc.2019.02.013_bb0150","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","article-title":"Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy","volume":"113","author":"Kong","year":"2006","journal-title":"Circulation"},{"issue":"47","key":"10.1016\/j.yjmcc.2019.02.013_bb0155","doi-asserted-by":"crossref","first-page":"39338","DOI":"10.1074\/jbc.M112.379115","article-title":"Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts","volume":"287","author":"Zhang","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.yjmcc.2019.02.013_bb0160","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.117.029343","article-title":"Cardiomyocyte regeneration: a consensus statement","volume":"136","author":"Eschenhagen","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.yjmcc.2019.02.013_bb0165","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.amjcard.2010.03.032","article-title":"Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy","volume":"106","author":"Turer","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.02.013_bb0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","article-title":"Therapeutic potential for HDAC inhibitors in the heart","volume":"52","author":"McKinsey","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.yjmcc.2019.02.013_bb0175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2014.03.005","article-title":"Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion","volume":"72","author":"Aune","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.02.013_bb0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.yjmcc.2017.12.004","article-title":"HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury","volume":"114","author":"Herr","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/j.yjmcc.2019.02.013_bb0185","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1073\/pnas.1015081108","article-title":"Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy","volume":"108","author":"Cao","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"422","key":"10.1016\/j.yjmcc.2019.02.013_bb0190","doi-asserted-by":"crossref","first-page":"ra34","DOI":"10.1126\/scisignal.aad5736","article-title":"Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression","volume":"9","author":"Morales","year":"2016","journal-title":"Sci. Signal."},{"issue":"6","key":"10.1016\/j.yjmcc.2019.02.013_bb0195","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.devcel.2010.05.005","article-title":"A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions","volume":"18","author":"Lipinski","year":"2010","journal-title":"Dev. Cell"},{"issue":"6116","key":"10.1016\/j.yjmcc.2019.02.013_bb0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2019.02.013_bb0205","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s11064-015-1700-4","article-title":"The ketone body, beta-Hydroxybutyrate stimulates the autophagic flux and prevents neuronal death induced by glucose deprivation in cortical cultured neurons","volume":"41","author":"Camberos-Luna","year":"2016","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2019.02.013_bb0210","doi-asserted-by":"crossref","first-page":"H1968","DOI":"10.1152\/ajpheart.00250.2002","article-title":"dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts","volume":"283","author":"Zou","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2019.02.013_bb0215","doi-asserted-by":"crossref","first-page":"567","DOI":"10.33549\/physiolres.932338","article-title":"Short-term fasting reduces the extent of myocardial infarction and incidence of reperfusion arrhythmias in rats","volume":"61","author":"Snorek","year":"2012","journal-title":"Physiol. Res."},{"key":"10.1016\/j.yjmcc.2019.02.013_bb0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-642-21631-2_4","article-title":"The biology and therapeutic implications of HDACs in the heart","volume":"206","author":"McKinsey","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"issue":"4","key":"10.1016\/j.yjmcc.2019.02.013_bb0225","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1159\/000358686","article-title":"Suv39h1 protects from myocardial ischemia-reperfusion injury in diabetic rats","volume":"33","author":"Yang","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"10.1016\/j.yjmcc.2019.02.013_bb0230","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/CIRCRESAHA.116.303630","article-title":"Readers, writers, and erasers: chromatin as the whiteboard of heart disease","volume":"116","author":"Gillette","year":"2015","journal-title":"Circ. Res."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818312045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818312045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:21:37Z","timestamp":1777418497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818312045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":46,"alternative-id":["S0022282818312045"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.02.013","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC inhibition as a therapeutic strategy in myocardial ischemia\/reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}